Modular Polypeptide Ligands for GSK3 Activity Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies lack effective modular inhibitors and subcellular localization methods for modulating GSK3 activity, which is crucial for regulating cellular signals and control mechanisms.
Innovation Solution
Development of polypeptide ligands and polyligands that can modulate GSK3 activity by modifying natural substrates through truncation or amino acid substitution, and by linking these ligands to subcellular localization signals to target specific cellular regions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polypeptide ligands are modified through truncation or amino acid substitution to create modular inhibitors, then the ability to modulate GSK3 activity is improved, but the structural complexity of the polypeptides increases
Solution Approach 1:
The polypeptide ligands are divided into modular domains that can be independently modified through truncation or amino acid substitution. This segmentation allows creation of customized inhibitors with specific GSK3 modulation properties while managing structural complexity through standardized modular units.
Solution Approach 2:
Systematic amino acid substitutions and truncations are performed to alter polypeptide parameters such as binding affinity, specificity, and stability. These parameter changes enable fine-tuning of GSK3 modulation while maintaining a manageable structural framework through controlled modifications.
2Measurement precision
If subcellular localization signals are linked to polypeptide ligands to target specific cellular regions, then the precision of GSK3 inhibition is improved, but the device complexity increases
Solution Approach 1:
Subcellular localization signals act as intermediary elements that mediate the targeting of polypeptide ligands to specific cellular compartments. These signal sequences serve as modular add-ons that direct ligand localization without fundamentally altering the core GSK3-binding domain, thus improving precision while adding controlled complexity.
Solution Approach 2:
The polypeptide construct is segmented into functional domains: the GSK3-binding ligand domain and the subcellular localization signal domain. This segmentation allows independent optimization of each function and simplifies the overall design by treating localization as a separate modular component.
3Adaptability or versatility
If natural substrates are modified to create polyligands, then the versatility of GSK3 modulation is improved, but the manufacturing complexity increases
Solution Approach 1:
Controlled parameter changes in natural substrates, such as specific amino acid substitutions or truncations, create polyligands with enhanced versatility for GSK3 modulation. These changes are implemented through standardized protocols that balance structural diversity with manufacturing feasibility.
Solution Approach 2:
Modified polyligands are designed to maintain universal binding capabilities to GSK3 while acquiring additional functional properties through modification. This multi-functionality allows a single polyligand structure to serve multiple modulation purposes, improving versatility without proportionally increasing manufacturing complexity.
Data Source
AI summary
The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.